OBJECTIVE: Adoption of effective treatments for recurrent binge-eating disorders depends on the balance of costs and benefits. Using data from a recent randomized controlled trial, we conducted an incremental cost-effectiveness analysis (CEA) of a cognitive-behavioral therapy guided self-help intervention (CBT-GSH) to treat recurrent binge eating compared to treatment as usual (TAU). METHOD:Participants were 123 adult members of an HMO (mean age = 37.2 years, 91.9% female, 96.7% non-Hispanic White) who met criteria for eating disorders involving binge eating as measured by the Eating Disorder Examination (C. G. Fairburn & Z. Cooper, 1993). Participants were randomized either to treatment as usual (TAU) or to TAU plus CBT-GSH. The clinical outcomes were binge-free days and quality-adjusted life years (QALYs); total societal cost was estimated using costs to patients and the health plan and related costs. RESULTS: Compared to those receiving TAU only, those who received TAU plus CBT-GSH experienced 25.2 more binge-free days and had lower total societal costs of $427 over 12 months following the intervention (incremental CEA ratio of -$20.23 per binge-free day or -$26,847 per QALY). Lower costs in the TAU plus CBT-GSH group were due to reduced use of TAU services in that group, resulting in lower net costs for the TAU plus CBT group despite the additional cost of CBT-GSH. CONCLUSIONS: Findings support CBT-GSH dissemination for recurrent binge-eating treatment.
RCT Entities:
OBJECTIVE: Adoption of effective treatments for recurrent binge-eating disorders depends on the balance of costs and benefits. Using data from a recent randomized controlled trial, we conducted an incremental cost-effectiveness analysis (CEA) of a cognitive-behavioral therapy guided self-help intervention (CBT-GSH) to treat recurrent binge eating compared to treatment as usual (TAU). METHOD:Participants were 123 adult members of an HMO (mean age = 37.2 years, 91.9% female, 96.7% non-Hispanic White) who met criteria for eating disorders involving binge eating as measured by the Eating Disorder Examination (C. G. Fairburn & Z. Cooper, 1993). Participants were randomized either to treatment as usual (TAU) or to TAU plus CBT-GSH. The clinical outcomes were binge-free days and quality-adjusted life years (QALYs); total societal cost was estimated using costs to patients and the health plan and related costs. RESULTS: Compared to those receiving TAU only, those who received TAU plus CBT-GSH experienced 25.2 more binge-free days and had lower total societal costs of $427 over 12 months following the intervention (incremental CEA ratio of -$20.23 per binge-free day or -$26,847 per QALY). Lower costs in the TAU plus CBT-GSH group were due to reduced use of TAU services in that group, resulting in lower net costs for the TAU plus CBT group despite the additional cost of CBT-GSH. CONCLUSIONS: Findings support CBT-GSH dissemination for recurrent binge-eating treatment.
Authors: Andrea E Kass; Katherine N Balantekin; Ellen E Fitzsimmons-Craft; Corinna Jacobi; Denise E Wilfley; C Barr Taylor Journal: Int J Eat Disord Date: 2017-02-02 Impact factor: 4.861
Authors: Fary M Cachelin; Munyi Shea; Phoutdavone Phimphasone; G Terence Wilson; Douglas R Thompson; Ruth H Striegel Journal: Cultur Divers Ethnic Minor Psychol Date: 2014-07
Authors: Lynn L DeBar; Ruth H Striegel-Moore; G Terence Wilson; Nancy Perrin; Bobbi Jo Yarborough; John Dickerson; Frances Lynch; Francine Rosselli; Helena C Kraemer Journal: Psychiatr Serv Date: 2011-04 Impact factor: 3.084
Authors: Marian Tanofsky-Kraff; Cynthia M Bulik; Marsha D Marcus; Ruth H Striegel; Denise E Wilfley; Stephen A Wonderlich; James I Hudson Journal: Int J Eat Disord Date: 2013-01-28 Impact factor: 4.861